Internal Medicine, Endocrinology, Diabetes, & Metabolism · Park Ridge, IL
NPI
1659807709
Since 2017
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1775 Ballard Rd
Park Ridge, IL, 60068
Phone (847) 318-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
3,510 services
Medicare patients, 2024
492
Average age 72
Drug cost, 2024
$2.5M
4,906 prescriptions
Company payments, 2024
$40.62
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irfan A Khan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 600 times for 349 patients. In total Irfan A Khan billed 3,510 services in 24 codes, and Medicare paid $135K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 600 | 349 | $13.03 | $7,817 |
| 99214 Office E&M - Established | Office | 594 | 332 | $94.18 | $56K |
| 36415 Venipuncture Blood Collection | Office | 550 | 298 | $8.57 | $4,714 |
| 99232 Hospital E&M - Subsequent | Facility | 308 | 80 | $63.48 | $20K |
| 95251 Test - Miscellaneous | Office | 225 | 104 | $27.44 | $6,175 |
| 99204 Office E&M - New | Office | 75 | 75 | $118.08 | $8,856 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 73 | 30 | $40.12 | $2,929 |
| 99222 Hospital E&M - Initial | Facility | 67 | 66 | $103.36 | $6,925 |
| 96372 Injection Administration | Office | 22 | 13 | $11.08 | $244 |
| 99215 Office E&M - Established | Office | 16 | 14 | $130.28 | $2,085 |
By year: 2022 $17K for 202 services; 2023 $87K for 1,625 services; 2024 $135K for 3,510 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 550 | 298 | $8.57 | $4,714 |
Medicare prescription drug claims, 2024
In 2024, the drug Irfan A Khan prescribed most often to Medicare patients was Levothyroxine Sodium, with 605 prescriptions and refills. In total Irfan A Khan wrote 4,906 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 605 | 1,711 | 180 | $7,672 |
| Ozempic Semaglutide | 231 | 467 | 78 | $440K |
| Metformin Hcl Generic | 222 | 649 | 76 | $1,749 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 202 | 556 | 99 | $27K |
| Jardiance Empagliflozin | 191 | 441 | 55 | $244K |
| Atorvastatin Calcium Generic | 162 | 472 | 58 | $1,813 |
| Trulicity Dulaglutide | 161 | 318 | 44 | $305K |
| Mounjaro Tirzepatide | 158 | 226 | 37 | $235K |
| Glipizide Generic | 148 | 400 | 58 | $1,597 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 147 | 391 | 69 | $30K |
| Repaglinide Generic | 146 | 405 | 62 | $4,933 |
| Metformin Hcl Er Metformin Hcl | 137 | 385 | 56 | $1,887 |
| Tresiba Flextouch U-100 Insulin Degludec | 129 | 373 | 61 | $146K |
| Humalog Kwikpen U-100 Insulin Lispro | 103 | 241 | 38 | $43K |
| Methimazole Generic | 98 | 272 | 30 | $1,356 |
Brand drugs: 2,264 claims; generic drugs: 2,141 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Irfan A Khan $40.62 ($40.62 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $24.55.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.